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Introduction
References & Acknowledgements
Bladder Dissection and UBM Delamination
Whole porcine bladders (Animal Biotech) were distended with 1L of PBS using a 
syringe and left overnight. The bladders were drained, cut open, and the detrusor 
muscle layer was mechanically delaminated from the luminal tissue. The resulting 
biomaterial is known as urinary bladder matrix (UBM).4
Decellularization and DNA Quantification
Protocol was adapted from a procedure developed by Gui et. al.5 Briefly, LB-ECM was 
rinsed in a hypotonic PIPES buffer followed by an SDS buffer. Finally, tissue was rinsed 
in endothelial cell medium. DNA content in UBM before and after decellularization was 
quantified via PicoGreen assay. Additionally, to qualitatively assess decellularization, 
native and decellularized UBM samples were fixed in paraformaldehyde, embedded in 
paraffin, sectioned, and stained with H&E.
Fig. 1. Schematic representation of UBM hydrogel fabrication. (a) Whole porcine bladders were cleaned, distended overnight, and dissected to isolate UBM. (b) 
Native UBM was decellularized to yield an acellular biomaterial. (c) Decellularized UBM was frozen, lyophilized, and ground into a particulate form. (d) Decellularized, 
powdered UBM was then fully digested in a pepsin solution over 72 hrs. (e) The resultant digested UBM was neutralized and diluted before gelation in a cylindrical 
mold at 37° C.






























Fig. 2. DNA content of native and decellularized UBM. Two sample t-
test was conducted for UBM DNA content before and after 
decellularization (n=3). Data is reported as mean ± standard deviation.
Fig. 3. H&E Staining of (a) native and (b) decellularized UBM sections. Brown 





























Fig. 4. L929 Fibroblast metabolic activity on UBM hydrogels after 72 hours. XTT 
absorbance fold change from t=4 hrs for varying UBM hydrogel substrate concentrations. One-
way ANOVA  (n=3, p*<0.05). Data is reported as mean ± standard deviation.
Fig. 6. Single-concentration UBM hydrogels and composite gradient hydrogel. 
(a) Macroscopic images of UBM hydrogels of 6, 11, and 16 mg/mL UBM concentration. (b) 
Brightfield cross-section of a hydrogel with an incorporated UBM density gradient. Scale bars = 





























Chronic, nonhealing wounds affect about 6.5 million individuals in the U.S., and 
often present as comorbidities of other prevalent conditions such as obesity and 
diabetes.1 Chronic wounds are characterized by a recurring inflammatory state without 
progression to the proliferation and remodeling stages of wound healing. Around $25 
billion is spent annually on treatment of chronic wounds; however most traditional 
wound care approaches do not effectively encourage the physiological healing 
process.2 One emerging treatment option is extracellular matrix (ECM)-based wound 
dressings, which are composed of a network of proteins and other macromolecules 
that support and anchor cells within tissue. These dressings are typically composed of 
decellularized tissue derived from animal donors and provide a protein scaffold that 
mimics dermal ECM by facilitating cell adhesion. Most commercially available ECM-
based dressings are dry, uniform sheets of ECM that provide a structural scaffold for 
cellular growth, but do not provide a physiologically relevant moisture balance or 
encourage cellular infiltration into the dressing as the wound heals. However, 
fibroblasts, which play a major role in wound healing, have been shown to migrate to 
regions of denser ECM concentrations, where they exhibit enhanced metabolic activity 
and proliferation.3
A UBM-based hydrogel will serve as an alternative wound dressing that will 
mitigate the issues with current ECM-based products. A hydrogel dressing offers a 
more physiologically relevant moisture balance to the site of the wound, while 
integrated structural cues will encourage fibroblast infiltration. Ultimately, this approach 
will increase the rate at which ulcers heal and prevent further deterioration of the 
wound site, in turn lessening the physical and financial burden on patients.
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We have successfully decellularized porcine UBM in order to prevent immunogenic 
responses to this UBM-based hydrogel wound dressing. We have also developed a 
mechanically stable hydrogel that contains a gradient of decellularized UBM. Fibroblast 
metabolic activity was shown to increase with UBM density, indicating that this gradient has 
the potential to increase cell survival as fibroblasts infiltrate into the hydrogel during the 
wound healing process. Furthermore, gradient UBM hydrogels exhibit height and mass loss 
in the presence of collagenase while the cross-sectional surface area of the wound 
dressing remains more stable with time. This finding is promising for the hydrogel’s overall 
ability to retain its shape over time while serving as a cellular scaffold in the wound bed.
Future studies will investigate gradient-induced cellular infiltration to assess the 
suitability of this graded hydrogel as a wound dressing. Functionalization of the UBM 
hydrogel with growth factors involved in wound healing, such as TGF-β1, will promote 
fibroblast recruitment and wound site fibrosis in order to accelerate wound healing and 
improve patient outcomes.
Conclusions & Future Work
Fig. 8. Hydrogel Dry Mass Loss in Collagenase. Percentage 
of original dry mass over 3 hr. incubation in collagenase I 
solution (n=3). Data is reported as mean ± standard deviation. 
a. b. c.
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Objective
The objective of this work is to design a hydrogel containing a gradient of porcine 
urinary bladder matrix (UBM) concentrations for wound dressing applications and to 
characterize its cellular response, rheological properties, and in vitro collagenase 
degradation.
Decellularization & Gelation
Following isolation and decellularization of porcine UBM (Fig. 1a,b), PicoGreen DNA content analysis showed 
that the overall DNA content was reduced from 4,402 ± 1341 ng DNA/mg dry tissue to 20.35 ± 17.66 ng DNA/mg dry 
tissue. This corresponds to a >99.5% reduction in native DNA content (Fig. 2). Decellularization was qualitatively 
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UBM Digestion and Gelation 
Decellularized UBM was lyophilized, digested, and reconstituted as a hydrogel as 
previously described.6 Briefly, decellularized UBM was lyophilized overnight, ground 
into a particulate form, and digested in a pepsin solution. The fully digested UBM 
solution was then neutralized, diluted, and injected into a cylindrical mold. Thermal 
gelation occurred when the pre-gel was heated to 37° C. 
UBM Gradient Hydrogel Fabrication
Gels with a gradient were fabricated by layering equal volumes of pre-gel solutions 
containing different UBM concentrations prior to gelation. Pre-gel solutions were 
viscous enough to prevent mixing, resulting in a three-layered gradient of differing 
UBM concentrations following gelation.
UBM-Based Hydrogels
Gradient Hydrogel Development
XTT analysis of cells seeded onto 15 and 16 mg/mL UBM hydrogels exhibited significantly greater metabolic 
activity than gels of 6-14 mg/mL UBM (Fig. 4), so 16 mg/mL was selected as the high-end UBM concentration for the 
gradient. The low-end UBM concentration selected was 6 mg/mL, as its diameter change over 48 hours in PBS was not 
significantly different than that of 16 mg/mL hydrogels (Fig. 5). Gradient gels were observed to have distinct regions of 
varying UBM concentrations (Fig. 6b,c), and the complex viscosity of gradient gels fell within the range of non-graded 
UBM gels, indicating integration of the three layers. (Fig. 7).
Collagenase Degradation
Fig. 7. Rheological characterization of UBM hydrogels. Complex 
viscosity |η*| for 6, 11, and 16 mg/mL and gradient UBM hydrogels 
over a range of frequencies (n=3). Data is reported as mean ±
standard deviation.
Fig. 5. Diameter change of UBM hydrogels. Percentage of original 
diameter after gelation over 48 hr incubation time in PBS. One-way 
ANOVA was conducted across all concentrations at t=48 hours (n=3). 






Fig. 9. Hydrogel Wet Mass Loss in Collagenase. Percentage of 
original hydrated mass over 3 hr incubation in collagenase I 
solution (n=3). Data is reported as mean ± standard deviation. 
Fig. 10. Hydrogel Height Change in Collagenase. Percentage 
of original gel height over 3 hr incubation in collagenase I 
solution (n=3). Data is reported as mean ± standard deviation .
Fig. 11. Hydrogel Cross-Sectional Area Change in 
Collagenase. Percentage of original cross-sectional area over 3 
hr incubation in collagenase I solution (n=3). Data is reported as 
mean ± standard deviation.
Hydrogels were digested in 100 μg/mL collagenase I solution to mimic gel degradation 
in vivo. While 6, 11, and 16 mg/mL and gradient hydrogels showed similar trends in mass and 
height reduction as they were degraded (Fig. 8, 9, 10), the surface area of 11 mg/mL, 16 
mg/mL, and gradient hydrogels remained relatively constant over 3 hour digestion (Fig. 11). 
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